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Abstract
Wound healing is a multistep phenomenon that relies on complex interactions between various cell types. Calpains are
ubiquitously expressed proteases regulating several processes including cellular adhesion and motility as well as
inflammation and angiogenesis. Calpains can be targeted by inhibitors, and their inhibition was shown to reduce organ
damage in various disease models. We aimed to assess the role of calpains in skin healing and the potential benefit of
calpain inhibition on scar formation. We used a pertinent model where calpain activity is inhibited only in lesional organs,
namely transgenic mice overexpressing calpastatin (CPST), a specific natural calpain inhibitor. CPST mice showed a striking
delay in wound healing particularly in the initial steps compared to wild types (WT). CPST wounds displayed reduced
proliferation in the epidermis and delayed re-epithelization. Granulation tissue formation was impaired in CPST mice, with a
reduction in CD45+ leukocyte infiltrate and in CD31+ blood vessel density. Interestingly, wounds on WT skin grafted on
CPST mice (WT/CPST) showed a similar delayed healing with reduced angiogenesis and inflammation compared to wounds
on WT/WT mice demonstrating the implication of calpain activity in distant extra-cutaneous cells during wound healing.
CPST wounds showed a reduction in alpha-smooth muscle actin (aSMA) expressing myofibroblasts as well as aSMA RNA
expression suggesting a defect in granulation tissue contraction. At later stages of skin healing, calpain inhibition proved
beneficial by reducing collagen production and wound fibrosis. In vitro, human fibroblasts exposed to calpeptin, a pan-
calpain inhibitor, showed reduced collagen synthesis, impaired TGFb-induced differentiation into aSMA-expressing
myofibroblasts, and were less efficient in a collagen gel contraction assay. In conclusion, calpains are major players in
granulation tissue formation. In view of their specific effects on fibroblasts a late inhibition of calpains should be considered
for scar reduction.
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Introduction
Skin wound healing is a multistep process that requires a close
interaction of multiple cell types in a coordinate and orderly
manner. In order to fill the defect, keratinocytes and fibroblasts
proliferate and migrate into the center of the wound. Besides, cells
from blood and bone marrow migrate into the wound and are
implicated in inflammation and angiogenesis [1,2,3,4,5,6]. All
these phenomena require integrity in fundamental processes such
as cell proliferation, motility and interaction with extracellular
matrix. In addition, wound healing crucially relies on the
mechanical activity of fibroblasts responding to TGFb1 and to
forces transmitted across focal adhesions formed essentially around
integrins and their signaling pathways [7]. Although wound
healing leads to the regeneration of normal skin in embryos and
fetuses, it results after birth in visible scarring that is featured by
excess collagen production and the absence of adnexa [8,9].
Calpains are intracellular calcium-dependent cystein proteases.
The major isoforms m-calpain (calpain-1) and m-calpain (calpain-
2) are ubiquitously expressed [10,11,12]. Both m and m-calpain are
heterodimers formed of a large subunit (80 kDa) specific for each
isoform and an identical small subunit (28 kDa) named calpain 4
[13]. The activities of m and m-calpains are redundant [14] and
specifically regulated by calpastatin, a specific endogenous
inhibitor [13]. Calpain activity enhances cell migration via
proteolysis of tallin and Focal Adhesion Kinase (FAK), disassembly
of focal adhesion complexes [15,16,17], reorganization of the
cytoskeleton and stabilization of cellular protrusions [18,19].
Calpain activity is required for induced keratinocyte motility via
disassembly of adhesion plaques in response to epidermal growth
factor (EGF) and Interferon-inducible protein 9 (IP-9, also known
as CXCL11) [10]. Calpains have also been reported as modulators
of multiple pathways of inflammation including the NF-kB
signaling pathway via degradation of IkBa [20], migration and
chemotaxis of neutrophils and monocytes via modulation of cell-
to-matrix adhesion [21,22]. Calpain activity is also required for
angiogenesis and endothelial cell modulation of adhesion and
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have been shown to be specifically affected by one of the two
ubiquitous calpains (m or m) [10,26], all in vivo studies were
performed using inhibition of both isoforms. In fact, the activities
of calpains m or m are redundant [14] possibly due to their high
sequence similarity and the shared calpain 4 sub-unit. They target
the same substrates and have a common natural inhibitor and no
specific inhibitor [13]. Therefore, in the literature as in this article
calpain activity refers to the activity of both m and m-calpains [27].
Interestingly, inhibiting calpain activity proved to be beneficial
and reduced tissue damage in experimental models of inflamma-
tory diseases [28,29], cancer progression (reviewed in [27]),
neurodegenerative [30] and cardiovascular diseases [31].
In the skin, m-calpain is involved in the catabolism of filaggrin
and filaggrin-2 during terminal differentiation of keratinocytes
[32,33], and the expression of both calpain m and m is increased
during skin wound healing [34]. In this study, we used calpastatin
transgenic mice (CPST). This is a pertinent model since calpain
activity is inhibited only in damaged organs. It allowed us to
precisely evaluate how calpain inhibition affects skin wound
healing in vivo and whether calpains can represent a putative
therapeutic target to limit tissue damage and scar formation.
Materials and Methods
Mice
8 weeks-old Calpastatin transgenic female mice (CPST) on
C57BL/6 background were used in these experiments [29,31].
Age-matched wild-type C57BL/6 female mice (WT) were
purchased from Janvier laboratories and used as controls.
Surgical wound healing assay
Mice were anesthetized by inhalation of isofluorane (AeraneH,
Baxter, Deerfield, IL). After depilation, 5 mm surgical wounds
were generated. All tissues above the panniculus carnosus were
excised. Wounds were performed on telogen stage skin, identified
by the absence of pigment. Wounds were left uncovered until they
were harvested.
Standardized pictures of the wounds were taken using a Sony
CybershotH 10.1 megapixels DSC-W180 digital camera. Wound
surfaces at each time-point were expressed as percentages of the
initial surface of each wound at day 0.
Skin graft experiment
After depilation, a 2-cm2 flap from the back skin was excised
and was then transplanted on recipient mice. Wounds were
performed on grafts 2 months after transplantation.
Microscopy, scoring and measurements
Five-micrometer cryosections were obtained. After permeabili-
zation with Triton X-100, sections were blocked using 20%
normal goat serum (DakoCytomation, Carpenteria, CA). Primary
antibodies used included purified rat anti-mouse CD45 (1:10; BD
Biosciences, Le Pont de Claix, France), rabbit anti-mouse Ki67
(1:200; Abcam Inc., Cambridge, MA), rabbit anti-Keratin 14
(1:500, Covance, Denver, PA), rat anti-Mouse CD31 (1:40; BD
Biosciences), rabbit anti-Mouse Lyve-1 (1:200; Abcam) and rabbit
anti-Mouse alpha-Smooth Muscle Actin (aSMA) (1/200; Abcam).
The secondary antibodies used were goat anti-rabbit IgG labeled
with FITC, goat anti-rabbit IgG labeled with Texas Red, and goat
anti-rat IgG labeled with Texas red (1:100; Jackson ImmunoR-
esearch, West Grove, PA). Slides were then counterstained with
0.3 mg/ml DAPI (Sigma-Aldrich, Lyon, France).
We used Nikon Eclipse 90i fluorescent microscope equipped
with Nikon DS-Fi1C digital camera. For cell scoring, photographs
of 3 different fields in the wound bed were taken and then labeled
cells were counted and reported as percentage of total DAPI
stained nuclei. Mean percentage of labeled cells was calculated for
each specimen. For epithelialization measurements, diametrical
sections were stained for keratin 14. The length of the newly
formed epidermis was calculated by adding together the lengths of
neo-epithelial tongues on both sides of the wound from the tip of
the epidermis to the site of the first hair follicle at the wound
margin. For vascular morphometric analysis, lymphatic and blood
vessel count and surface were measured on 3 different fields on
double-labeled section for CD31 and Lyve-1 as previously
described [35]. Cell counts of CD45+ and aSMA+ cells in the
granulation tissue were performed on 3 different fields on stained
sections. Proliferating cells were assessed separately in the
granulation tissue and at the epidermal wound edges. Fibrosis
was quantified by measuring the surface of Sirius Red staining in
the granulation tissue on diametrical sections of the wounds at day
10. The first hair follicles located deep in the dermis at both edges
of the wounds were considered as the external limits of the
granulation tissue. Measurements were done using ImageJ
software (NIH).
RNA extraction and quantitative PCR
Total RNA was extracted from in vitro differentiated fibroblasts
and from skin wounds using the RNeasy total RNA Mini kit
(Qiagen, Courtaboeuf, France). Total RNA (1 mg) was reverse
transcribed using high capacity cDNA reverse transcription kit
(Applied Biosystems, Courtaboeuf, France). Real-time PCR was
conducted using SYBRHGREEN PCR Master Mix (Applied
Biosystems) on ABI Prism 7300 (Applied Biosystems). mRNA
values were normalized to the expression level of HPRT
(Hypoxanthine-Guanine-Phospho-Ribosyl-Transferase) in human
MRC-5 fibroblasts or RPS3 (ribosomal protein S3) in murine skin
wounds. Each sample was analyzed in duplicate. Primer sequences
were (Forward and Reverse; 59-39): CCAGCCGCAAAGAGTC-
TACA and TCAAGCATACCTCGGGTTTC for mCOL1A1,
TTTGTGCAAAGTGGAACCTG and CGCAAAGGACAGAT-
CCTGA for mCOL3A1, CTCCCTGGAGAAGAGCTACG and
ATAGGTGGTTTCGTGGATGC for mA-SMA, ATCAGA-
GAGTTGACCGCAGTTG and AATGAACCGAAGCACAC-
CATAG for mRPS3, ATGTTCAGCTTTGTGGACCTC and
CTGTACGCAGGTGATTGGTG for hCOL1A1, CTGTTCC-
AGCCATCCTTCAT and TCATGATGCTGTTGTAGGTG-
GT for hA-SMA, GGACCTCCTGGTGCTATAGGT and CG-
GGTCTACCTGATTCTCCAT for hCOL3A1, AGTTGAGA-
GATCATCTCCAC and TTGCTGACCTGCTGGATTAC for
hHPRT.
Fibroblast differentiation assay
Confluent cultures of Human MRC-5 fibroblast line were
serum-starved for 48 hours, incubated with Calpeptin (20 or
40 mM) or vehicle (DMSO), then treated with 10 ng/ml TGF-b1
(PeproTech, Rocky Hill, NJ) or Phosphate-Buffered Saline (PBS)
vehicle for 72 hours [36].
Collagen gel contraction
Analysis of floating collagen gel contraction was performed as
previously described [36,37]. Ice-cold Collagen I Rat Tail
(Invitrogen, Paisley) was diluted at 30% v/v in serum free culture
medium and then mixed with fibroblasts (10
5 cells/ml) and 10 ng/
ml TGF-b1, with Calpeptin (40 mM) (Calbiochem, Merck KGaA,
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37084Figure 1. Delayed wound healing in CPST mice. Normal skin sections of CPST and WT mice stained with Hematoxylin-Eosin-Safran (A) and Sirius
Red(B) donotshowanydifferences at steady state.5 mmpunchbiopsieswere performed onCPST andWT mice.Photographs (C)andsurface (D)of the
woundsatmultipletimepoints showingdelayedwoundclosureinCPSTmice.Diametricalsections ofwounds stainedwithHematoxylin-Eosindepicting
neo-epidermis (dashed lines) (E) and length of neo-epidermis on keratin 14-labeled sections (F) showing delayed reepidermization in CPST mice. n=7
per group per time point. Scale bars: (A and B) 100 mm, (E) 500 mm. (D) Mann-Whitney test, (F) ANOVA, *P,0.05; ***P,0.001. (D and F) mean +/2SEM.
doi:10.1371/journal.pone.0037084.g001
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area were measured every 24 hours for 5 days.
Statistical analysis
Data were expressed as means 6 SEM. Means between 2
groups were compared using the Mann Whitney test. Differences
between multiple groups were analyzed by 1-way ANOVA.
P,0.05 was considered to be statistically significant.
Results
Wound healing and re-epithelialization are delayed in
CPST mice
To address our hypothesis that calpain activity is essential
during skin wound healing, we have used well-characterized
transgenic mice that overexpress calpastatin, a natural and specific
inhibitor of both m and m-calpains. Homozygous calpastatin
transgenic mice (CPST) do not show a skin phenotype at steady
state. Morphology of the epidermis and dermis were in accordance
similar to WT controls (figure 1A and B). We performed 5 mm
excisional wounds on the back of CPST and WT mice and
monitored wound closure. Healing was strikingly delayed in CPST
wounds particularly at the initial stages (mean wound surface on
day 3: CPST vs WT=115% vs 41%, p,0.0001, ANOVA)
(Figure 1 C and D).
Analysis of the wound specimens enabled us to decipher more
precisely the cellular mechanismsi nt h i sh e a l i n gd e l a y .W ef i r s t
assessed the re-epithelialization by measuring the length of the newly
formed epidermis covering the granulation tissue at different time
points. Neo-epidermis was significantly shorter in CPST mice as
Figure 2. Impaired proliferation and granulation tissue formation in CPST wounds. Ki67 staining (red) on CPST and WT wound sections at
day 7 (A) showed reduced numbers of proliferating cells in the epidermal wound edges and the granulation tissue dermal cells (B). CD45 staining
(red) and counts (C and D) on day 3 wound sections showed reduced numbers of inflammatory cells in CPST wound beds (D). a-Smooth-Muscle-Actin
staining (aSMA) (red) and counts (E and F) showed reduced numbers of myofibroblasts in CPST wounds. mRNA levels of aSMA in day 3 CPST and WT
wounds. Representative photos of wound edges are depicted in A; epidermis is delineated in dashed lines. Representative photos of wound
granulation tissue are depicted in (C) and (E). Nuclei were stained with DAPI (blue). n=7 per group. Scale bars: (A) 100 mm, (C and E) 50 mm. Mann-
Whitney test, *P,0.05, **P,0.01. (B, D, F and G) mean +/2SEM.
doi:10.1371/journal.pone.0037084.g002
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accompanied by a lower number of Ki67 positive proliferating
keratinocytes in the CPST wound edges on day 7 (Figure 2A and B).
Impaired granulation tissue formation in CPST mice
We also observed reduced numbers of Ki67+ proliferating cells
in the wound beds of CPST mice compared to WT (Figure 2B)
indicating an alteration of granulation tissue formation. The
number of inflammatory CD45+ cells was significantly reduced in
CPST wounds (CPST vs WT, 19% vs 34% of total cells, p,0.05,
Mann-Whitney) (Figure 2C and D). There was also a lower
number of aSMA+ contractile myofibroblasts in CPST wounds
(CPST vs WT, 8% vs 16% of total cells, p,0.01, Mann-Whitney)
(Figure 2E and F). This was in accordance with a lower aSMA
mRNA levels in CPST wounds measured on the same time point
(Figure 2G). Finally, quantitative assessment of blood and
lymphatic angiogenesis was done on wound sections double-
labeled for CD31 and Lyve1: CPST wounds showed a significant
decrease in blood vessel density and an important, although not
significant, decrease in blood vessel surface when compared to
controls (Figure 3A–C).
Impaired cell recruitment in the wound beds of CPST
mice
Wound healing leads to recruitment of cells from peripheral
circulation or marrow [1,2]. Therefore, we addressed the
contribution of local versus systemic calpain inhibition in the
observed delay in wound healing in CPST mice. Skin flaps were
transplanted from WT mice on the back of CPST recipient mice
(WT/CPST). Controls were CPST skin transplanted on CPST
mice (CPST/CPST) and WT skin on WT mice (WT/WT). Two
months after transplantation, 4 mm excisional wounds were
performed on the grafts and the healing was monitored. As
expected, CPST/CPST wounds healed significantly slower than
WT/WT ones. Interestingly, there was also a significant delay in
closure of WT/CPST wounds when compared with WT/WT
wounds (Figure 4A and B). This suggested that the systemic
calpain inhibition in CPST recipients affected healing in CPST
mice, rather than a defect in CPST skin cells. On the other side,
WT/CPST wounds did not heal faster than the CPST/CPST
wounds also indicating that the grafted skin components, especially
the epidermis, were not directly involved in the delayed healing
observed in CPST wounds. In situ analysis of the wounds showed a
decrease in the inflammatory cell infiltrate in WT/CPST wounds
as compared to WT/WT wounds (Figure 4C). There was also a
significant decrease of blood vessel surface in WT/CPST
compared to WT/WT wounds. Interestingly, CPST/CPST
wound beds showed a significant decrease in wound angiogenesis
compared to WT/CPST specimens (Figure 4D) suggesting that
both local and distant cell mobilization and/or proliferation –that
participate in wound inflammation and angiogenesis– were
calpain dependent.
Calpain inhibition reduces collagen deposition in wound
beds and inhibits myofibroblast differentiation
The decrease in aSMA+ myofibroblasts in CPST wounds
prompted us to assess the contractile function of skin fibroblasts
and collagen deposition in CPST mice. On day 10, Sirius Red
staining showed a tendency towards reduced fibrosis in CPST
wounds (Figure 5A and B). Accordingly, collagen1A1 and
Figure 3. Impaired angiogenesis in CPST wounds. Wound sections (day 7) of CPST and WT mice were double-labeled for CD31 (red) and Lyve1
(green). Nuclei were stained with DAPI (blue). Representative photos of wound granulation tissue in WT and CPST mice are depicted in (A). Number
(B) and surface (C) of blood and lymphatic vessels in the wound beds. n=7 per group. Scale bar (A) 100 mm. Mann-Whitney test, *P,0.05. (B and C)
mean +/2SEM.
doi:10.1371/journal.pone.0037084.g003
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CPST than in WT wounds (Figure 5C). There was also a trend
towards a decrease in TGFb1 mRNA levels in CPST wounds
(Figure 5D). TGFb is known to induce fibroblast differentiation
into contractile myofibroblasts and to stimulate the synthesis of
type I collagen that replaces the early type III collagen [38,39]. To
analyze the role of calpains on fibroblast response to TGFb,w e
stimulated human MRC-5 fibroblasts with TGFb in the presence
of calpeptin, a pan-calpain inhibitor. On qPCR, calpeptin
significantly inhibited TGFb-induced aSMA RNA levels
(Figure 6A). Calpain inhibition also reduced collagen I expression
by fibroblasts upon TGFb stimulation and Collagen III transcrip-
tion at steady state (Figure 6B and C). Moreover, calpeptin
inhibited TGFb-stimulated collagen gel contraction in a dose-
dependent manner showing that calpain inhibition alters the
fibroblast/myofibroblast contractile properties (Figure 6D).
Discussion
This study shows that the in vivo inhibition of calpains does not
alter the overall structure of the normal skin while it deeply
modifies wound healing by affecting all the steps of this process. In
mice overexpressing calpastatin, a physiological inhibitor of
calpains, the healing was strikingly delayed mainly in the early
stages. The proliferation of keratinocytes and granulation tissue
cells, the density of the inflammatory infiltrate and of blood vessels
Figure 4. Impaired cell recruitment in the wound beds of CPST mice. WT Skin flaps were transplanted on the back of CPST recipients
(CPST+grWT) with corresponding controls (a). 2 months after transplantation, excisional biopsies were performed on grafts and monitored over time.
Photographs (A) and surface (B) of the wounds at different time points. Number of CD45 positive cells (C) and surface of CD31+ blood vessels (D)
were evaluated. n=6 per group. Mann-Whitney test, *P,0.05; **P,0.01. (B–D) mean +/2SEM.
doi:10.1371/journal.pone.0037084.g004
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collagen production and both collagens I and III transcription
were reduced in CPST wounds. This was in accordance with in
vitro data showing that calpain inhibition in a human fibroblast cell
line led to a reduction of collagen I synthesis, myofibroblast
differentiation and contractile function.
Calpastatin inhibits both m and m-calpains. Thus, the impaired
wound healing observed in CPST mice cannot be strictly
attributed to one of the two isoforms. However, several in vitro
studies showed that there is a redundancy in the cellular functions
of m and m-calpain. In a murine embryonic fibroblast line, only a
knock down of the shared sub-unit calpain 4 –and not of m or m-
calpain alone– inhibits the contractile and adhesive properties of
the cells [14]. Moreover, mice bearing a constitutional knockout of
m-calpain do not display an overt phenotype except for a moderate
platelet dysfunction [40]. Calpastatin transgenic mice used in this
work are a reference model to study the role of calpain activity in
the pathophysiology of organ damage. In fact, in these mice,
calpain activity is not reduced under steady state conditions while
it is inhibited by the transgene only in damaged tissues [41,42].
Since m and m-calpains are both up-regulated in skin wounds and
since calpain activity is only inhibited under pathologic conditions
in CPST mice, our model appeared as a pertinent one to assess
calpain activity implication in wound healing.
Calpain activity appeared essential in the establishment of the
inflammatory phase of wound healing since the CD45+ cells were
significantly reduced in mice overexpressing calpastatin. Since
both m and m-calpains display two peaks occurring at days 1 and 5
of the wound healing [34], the data we show here suggests that the
first peak corresponds to the early inflammatory step in healing
[34]. During this stage, the wound bed is infiltrated with a high
number of neutrophils and macrophages [4,5,43]. These derive
from the recruitment of circulating inflammatory cells as well as
the recruitment of hematopoietic progenitor cells from the bone
marrow [1,44]. The graft experimentations that we performed
showed a reduction in CD45+ cells in wounds on WT skin grafted
on CPST recipients. These data indicate that the calpain activity
in the distant niche of inflammatory cells per se is important for
their recruitment in wound beds independently of the skin
background. In fact, in human differentiated neutrophils as well
as in monocytes, calpain inhibition was shown to increase
migration and chemotaxis in vitro [45,46]. On the other hand,
calpain inhibition reduces the TNFa-induced adhesion of neutro-
phils and promotes random migration, suggesting that calpains
mediate the arrest signal of these cells at sites of inflammation [22].
Our results as well as others in experimental glomerulopathy [29],
pleurisy or arthritis [28] confirm in vivo the importance of calpains
in the build-up of inflammation potentially through this mecha-
nism.
Calpastatin transgenic mice displayed reduced angiogenesis in
their wound beds. The wounds on WT skin transplanted on CPST
recipients showed decreased vessel surface as compared to WT
Figure 5. Calpain inhibition reduces scar formation in skin wounds. Day 10 Wounds of CPST mice show less Sirius Red staining and more
epidermal adnexa regeneration compared to WT mice (A). Relative surface of Sirius Red staining in WT and CPST wounds on day 10 (B). mRNA levels
of Collagen1A1 and TGFb1 in day 3 CPST and WT wound (C and D). (A–D) n=7 per group. Scale bars: (A) 500 mm. Mann-Whitney test, *P,0.05. (B–D)
mean +/2SEM.
doi:10.1371/journal.pone.0037084.g005
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CPST skin grafted on CSPT recipients was also significantly
reduced as compared to WT grafts on CPST recipients. It is well
known that recruited monocytes/macrophages play a key role in
promoting skin wound angiogenesis [5]. On the other hand vessel
formation in the wound bed results from the budding of dermal
endothelial cells; while the contribution of circulating endothelial
progenitors has recently been questioned [47]. Our graft
experimentations indicate that local but also distant cells or
progenitors were implicated in wound angiogenesis and that both
were affected by calpain inhibition. All these results are in
accordance with the increase of m-calpain expression and activity
found in endothelial cells after VEGFa stimulation. Calpain
activity promotes angiogenesis through enhanced cell detachment
from matrix and reorganization of cytoskeleton [23,25,48].
Calpain inhibition was beneficial in late stages of wound healing
featured by a reduction in collagen I, aSMA and TGFb expression
and scar formation. This may correspond to the second peak of
calpain activation after skin wounding [34]. The link between
inflammation and fibrosis is very tight in skin wound healing [49]
as well as in other tissue injuries as in myocardial fibrosis
secondary to hypertension [50]. Accordingly, it has recently been
shown that collagen deposition and scarring during wound healing
can be affected by early macrophage depletion [5]. Macrophages
are a major source of TGFb during wound healing [51,52]. Thus,
the decrease in wound fibrosis observed in CPST mice could be –
at least partly– caused by a reduced inflammatory cell infiltrate in
the granulation tissue. We also observed a decrease in TGFb
expression in CPST wounds. In a previous work, two of us (E.L.
and L.B.) showed –using the same transgenic mice– that
calpastatin overexpression limits hypertension-induced intimal
fibrosis in blood vessels via a decrease in inflammatory cell
recruitment and secretion of MIP-1 [31]. These data are also in
line with multiple studies showing that, despite the pleiotropic
effect of calpains in basic cell functions, inhibiting calpain activity
limits tissue damage in target organs [28,29,42].
Finally, our results clearly show that calpain inhibition has
direct effects on fibroblasts regardless of inflammation. Indeed,
expression of collagen I and III by fibroblasts was inhibited by
calpeptin, a calpain inhibitor. Morevover, calpeptin significantly
inhibited TGF-b induced collagen I overexpression. The in vivo
microenvironment influences collagen production by fibroblasts
through a large spectrum of molecules, TGFb being classically the
most important. Beside collagen deposition, wound contraction
participates to scar formation in later stages of wound healing
[38,53,54]. Skin wounds of CPST mice showed lower numbers of
aSMA positive myofibroblasts in wound sections and lower aSMA
mRNA levels in wound extracts. Pharmacologic inhibition of
calpain activity by calpeptin limits fibroblast differentiation into
aSMA positive myofibroblasts in vitro, and limits their contractile
Figure 6. Calpain inhibition inhibits myofibroblast differentiation, contraction and collagen synthesis. MRC-5 fibroblasts were
stimulated with TGFb1 with or without addition of Calpeptin. mRNA levels of aSMA (A), Collagen1A1 (B) and Collagen3A1 (C) after TGFb1 stimulation.
MRC-5 cells embedded in floating collagen gels were stimulated with TGFb1. Photos (D) of collagen gels with or without Calpain inhibition with
Calpeptin. (A–D) n=4. (A–C) Mann-Whitney test; (D) ANOVA; *P,0.05; **P,0.01. (A–D) mean +/2SEM.
doi:10.1371/journal.pone.0037084.g006
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of bleomycin-induced lung fibrosis where collagen1A1 synthesis in
lung fibroblasts was also inhibited by calpastatin [55].
In conclusion, our study sheds new light on the role of calpains
in wound healing. Although calpain inhibition of inflammatory
cell recruitment and angiogenesis in the early stages of wound
healing delays the healing, the reduction in scar formation
observed at later stages has proven beneficial. The latter effect
seems to be due to a direct effect on fibroblasts and their response
to TGFb. Calpains are target proteins that should therefore be
considered for further studies in scar formation and skin fibrosis.
Moreover, new calpain inhibitors are now developed and trials are
conducted in clinical areas as Alzheimer’s disease and cardiovas-
cular disorders. Special attention should be paid to wound healing
and ulcer development in these patients [56].
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